A Phase 1, open-label, study to investigate pharmacokinetics, effect of food and safety of a new immediate-release formulation of zoliflodacin and optional single dose study to assess pharmacokinetics, safety, and tolerability of zoliflodacin in healthy subjects

[Published: 15 May 2018]

GARDP is currently sourcing a Contract Research Organization (CRO) in United States of America able to perform a Food Effect Study for Zoliflodacin product.